Evaluating the Acceptability, Feasibility and Usability of Various Conversational Data Collection Software

NCT ID
NCT07336537
Registry status
Recruiting
Study type
Interventional
Phase
Not applicable
Sponsor
AugMend Health Inc.
Conditions
Behavioral Health Challenges, Chronic Pain, Ecological Momentary Assessment Best Practices, Mental Health Disorders

Overview

ClinicalTrials.gov lists this study as Recruiting.

Official title: Evaluating the Acceptability, Feasibility and Usability of Various Digital Biopsychosocial Conversational Data Collection Software in a Patient Population With Chronic Pain

Enrollment: 100 participants (Estimated).

What is being studied

  • Other: Digital Biopsychosocial Conversational Data Collection Software
  • Other: Standard Digital Questionnaire Data Collection

Who may be eligible

Ages
18 Years to no maximum
Sex
All
Healthy volunteers accepted
No

ClinicalTrials.gov lists the following eligibility criteria.

Inclusion Criteria: * Adults aged 18 years or older * Diagnosis of chronic pain (pain lasting 3 months or longer) * Able to read and understand English * Able to provide informed consent * Willing and able to complete study procedures either at home or at the MIT.nano Immersion Lab * Access to necessary technology for home-based participation (if assigned to home-based group), or ability to travel to the MIT.nano Immersion Lab (if assigned to laboratory-based group) * Cognitively able to interact with digital data collection software and provide feedback Exclusion Criteria: * Under 18 years of age * Unable to provide informed consent * Non-English speaking * Acute pain only (pain lasting less than 3 months) * Cognitive impairment that would prevent meaningful interaction with data collection software or ability to provide valid feedback * Unable or unwilling to complete study procedures in assigned setting (home or laboratory) * Any condition that, in the opinion of the investigator, would make participation unsafe or interfere with the participant's ability to complete study procedures

Study locations

1 study location is listed.

Recruiting site status is explicitly provided for 1 location; 1 is listed as Recruiting.

Countries: United States

  • Massachusetts, United States: 1

Sample of listed locations

  • AugMend Health at MIT.nano Immersion Lab — Cambridge, Massachusetts, 02139, United States — Recruiting

Study details

Start date
October 3, 2025
Primary completion date
February 11, 2026
Completion date
July 31, 2026
First posted
January 13, 2026

Source and update information

Source
ClinicalTrials.gov
NCT ID
NCT07336537
Registry last updated
January 13, 2026
QualifiedStudies registry data refreshed
October 2, 2026
QualifiedStudies record fetched
October 2, 2026

View NCT07336537 on ClinicalTrials.gov

Trial information can change. Confirm current study details with the study team or the registry.

About joining clinical research

Find clinical trials you may match with

QualifiedStudies can help you search for research opportunities related to your health. Availability of this specific study through QualifiedStudies has not been established.

Find clinical trials you may match with | Clinical trial FAQ